Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1985-03-07
1986-05-06
Bond, Robert T.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
2602393B, A61K 3155, C07D28110
Patent
active
045872422
ABSTRACT:
A pharmaceutical compound characterized by a delayed release of the therapeutically active component, comprising a sulfonic type ion exchange resin and cis(.+-.)-3-acetyloxy-5-[2-(dimethylamino)ethyl]-2,3-dihydro-2-(4-methoxyp henyl)-1,5-benzothiazepin-4(5H)one, or cis(.+-.)-3-hydroxy-5-[2-(dimethylamino)ethyl]-2,3-dihydro-2-(4-methoxyphe nyl)-1,5-benzothiazepin-4(5H)one as a therapeutically active compound.
A process for the preparation of the active compound.
A pharmaceutical composition including said active compound, and use of said composition for the prophylaxis and therapy of acute and chronical coronary insufficiency and of arterial hypertension.
REFERENCES:
patent: 3562257 (1971-02-01), Kugita et al.
patent: 3646008 (1972-02-01), Kugita et al.
Cascio Giuseppe
Manghisi Elso
Bond Robert T.
Instituto Lusofarmaco d'Italia S.p.A.
LandOfFree
Sulfonic resins having a therapeutical activity, preparation the does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sulfonic resins having a therapeutical activity, preparation the, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sulfonic resins having a therapeutical activity, preparation the will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1574736